Increase in sales volume set to benefit Hartalega

CIMB Research expects stronger prospects for the company from 2H25 onwards, mainly backed by an expected surge in glove demand from the United States clients.

PETALING JAYA: Hartalega Bhd is poised to benefit from increases in sales volume and average selling prices (ASPs) thanks to higher US tariffs on China-imported medical gloves from 2025 onwards.

These positive factors will support the glove maker to post stronger results in the second half of financial year 2025 (2H25), CIMB Research said in a report yesterday.